Delivery Order SPE2DB22D3401-SPE2DB24FT1RZ

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $2.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide LUPRON DEPOT 11.25 MG 3MO KITS. This $20,390.52 contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $4,926.04 to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, with a performance period ending on May 10, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LUPRON DEPOT 11.25 MG 3MO KITS. This $4,011.24 contract has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation noted. The company holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a $14,303.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564309694 LUPRON DEPOT 11.25 MG 3MO KITS. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LUPRON DEPOT 3.75 MG KITS. The award has a completion date of January 29, 2024 and a potential value of $1,424.48. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
This firm fixed price delivery order, valued at $1,388.43, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of LUPRON DEPOT 22.5 MG 3MO KITS, a pharmaceutical product, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is the sole awardee on this contract, which is not associated with any set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a $5,224.96 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LUPRON DEPOT 45 MG 6MO KITS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LUPRON DEPOT 3.75 MG KITS. This firm-fixed-price contract has a ceiling value of $4,551.83 and a completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $11,232.71 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, a medication used to treat certain medical conditions. The contract has a completion date of April 23, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,555.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product, with a performance period through March 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT1RZ
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LUPRON DEPOT 11.25 MG 3MO KITS, a pharmaceutical product, with a potential value of $2,111.16. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order was issued under an Indefinite Delivery Contract (IDC) the company holds with DLA, valued up to $999,999,999.00, to deliver pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities. No set-aside designation was used for this contract award.

Generated 5/2/24, 11:00 AM